Poniard Pharmaceuticals, Inc.

7000 Shoreline Court
Suite 270
South San Francisco
California
94080
United States

Tel: 650-583-3774
Fax: 650-583-3789

Show jobs for this employer

About Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead product candidate, is a new generation platinum therapy with an improved safety profile. Picoplatin is designed to overcome and prevent platinum resistance associated with chemotherapy in solid tumors. Picoplatin is currently being studied in clinical trials for the treatment of small cell lung, colorectal and hormone-refractory prostate cancers. As part of the Company's strategic goal of building a diverse oncology pipeline, the Company is collaborating with The Scripps Research Institute on the discovery of novel, small-molecule, multi-targeted protein kinase inhibitors.

For additional information, please visit www.poniard.com.

171 articles about Poniard Pharmaceuticals, Inc.